Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-21

Clinical Trial Update: Safety and Efficacy of Ketoconazole 2% Foam in the Treatment of Pityrosporum Folliculitis [Phase 4]

View source ↗

Summary

A Phase 4 trial update examining the safety and efficacy of 2% ketoconazole foam in treating pityrosporum folliculitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketoconazole 2% Foam (ketoconazole)

Snippet

Sponsor: Wayne Fujita, M.D. | Conditions: Pityrosporum Folliculitis | Phase 4 | Status: COMPLETED